Vaccine-maker Novavax kicks off trial for combined Covid-19/flu jab – https://t.co/vRNDpIpI8s –
American vaccine-maker Novavax has started its early stage trial of a vaccine which combines an as-yet-unapproved Covid-19 shot with the company’s NanoFlu influenza jab.
— kashco.co.uk (@Kashco_co_uk) September 8, 2021
“Combination of these two vaccines… may lead to greater efficiencies for the healthcare system and achieve high levels of protection against Covid-19 and influenza with a single regimen,” Novavax’s president of research and development Gregory Glenn said in a statement.
The firm has been touted as a leader in the race to safely and effectively combine flu and Covid-19 vaccines. Novavax said in May that it expects seasonal flu and Covid-19 combo vaccines to be vitally important in controlling the spread of the pandemic.